Global Hepatitis A Vaccine Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Hepatitis A Vaccine Market
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Due to the COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 809 million in 2022 and is forecast to a readjusted size of US$ 916.5 million by 2028 with a CAGR of 2.1% during the review period. Fully considering the economic change by this health crisis, Inactivated Vaccine accounting for % of the Hepatitis A Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Government Institution segment is altered to an % CAGR throughout this forecast period.

Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.

Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.

In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Segment by Application

Government Institution

Private Sector

Other

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Hepatitis A Vaccine market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCA

ChangSheng

Convac

TABLE OF CONTENT

1 Study Coverage
1.1 Hepatitis A Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Inactivated Vaccine

1.2.3 Live Attenuated Vaccine

1.3 Market by Application

1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028

2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028

2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Hepatitis A Vaccine Sales by Region

2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022)

2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028)

2.5 Global Hepatitis A Vaccine Revenue by Region

2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022)

2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Hepatitis A Vaccine Sales by Manufacturers

3.1.1 Global Top Hepatitis A Vaccine Manufacturers by Sales (2017-2022)

3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis A Vaccine in 2021

3.2 Global Hepatitis A Vaccine Revenue by Manufacturers

3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2017-2022)

3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Revenue in 2021

3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Hepatitis A Vaccine Sales by Type

4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022)

4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028)

4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)

4.2 Global Hepatitis A Vaccine Revenue by Type

4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022)

4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028)

4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)

4.3 Global Hepatitis A Vaccine Price by Type

4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022)

4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Hepatitis A Vaccine Sales by Application

5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022)

5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028)

5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)

5.2 Global Hepatitis A Vaccine Revenue by Application

5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022)

5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028)

5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)

5.3 Global Hepatitis A Vaccine Price by Application

5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022)

5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028)

6 North America

6.1 North America Hepatitis A Vaccine Market Size by Type

6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)

6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028)

6.2 North America Hepatitis A Vaccine Market Size by Application

6.2.1 North America Hepatitis A Vaccine Sales by Application (2017-2028)

6.2.2 North America Hepatitis A Vaccine Revenue by Application (2017-2028)

6.3 North America Hepatitis A Vaccine Market Size by Country

6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028)

6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Hepatitis A Vaccine Market Size by Type

7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)

7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028)

7.2 Europe Hepatitis A Vaccine Market Size by Application

7.2.1 Europe Hepatitis A Vaccine Sales by Application (2017-2028)

7.2.2 Europe Hepatitis A Vaccine Revenue by Application (2017-2028)

7.3 Europe Hepatitis A Vaccine Market Size by Country

7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028)

7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type

8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028)

8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028)

8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application

8.2.1 Asia Pacific Hepatitis A Vaccine Sales by Application (2017-2028)

8.2.2 Asia Pacific Hepatitis A Vaccine Revenue by Application (2017-2028)

8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region

8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028)

8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Hepatitis A Vaccine Market Size by Type

9.1.1 Latin America Hepatitis A Vaccine Sales by Type (2017-2028)

9.1.2 Latin America Hepatitis A Vaccine Revenue by Type (2017-2028)

9.2 Latin America Hepatitis A Vaccine Market Size by Application

9.2.1 Latin America Hepatitis A Vaccine Sales by Application (2017-2028)

9.2.2 Latin America Hepatitis A Vaccine Revenue by Application (2017-2028)

9.3 Latin America Hepatitis A Vaccine Market Size by Country

9.3.1 Latin America Hepatitis A Vaccine Sales by Country (2017-2028)

9.3.2 Latin America Hepatitis A Vaccine Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type

10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028)

10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028)

10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application

10.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Application (2017-2028)

10.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Application (2017-2028)

10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country

10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028)

10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 GSK

11.1.1 GSK Corporation Information

11.1.2 GSK Overview

11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 GSK Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GSK Recent Developments

11.2 Merck

11.2.1 Merck Corporation Information

11.2.2 Merck Overview

11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merck Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merck Recent Developments

11.3 Sanofi

11.3.1 Sanofi Corporation Information

11.3.2 Sanofi Overview

11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Sanofi Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Sanofi Recent Developments

11.4 Sinovac

11.4.1 Sinovac Corporation Information

11.4.2 Sinovac Overview

11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Sinovac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sinovac Recent Developments

11.5 Zhejiang Pukang

11.5.1 Zhejiang Pukang Corporation Information

11.5.2 Zhejiang Pukang Overview

11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Zhejiang Pukang Recent Developments

11.6 Changchun Institute of Biological

11.6.1 Changchun Institute of Biological Corporation Information

11.6.2 Changchun Institute of Biological Overview

11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Changchun Institute of Biological Recent Developments

11.7 KM Biologics

11.7.1 KM Biologics Corporation Information

11.7.2 KM Biologics Overview

11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 KM Biologics Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 KM Biologics Recent Developments

11.8 IMBCA

11.8.1 IMBCA Corporation Information

11.8.2 IMBCA Overview

11.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 IMBCA Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 IMBCA Recent Developments

11.9 ChangSheng

11.9.1 ChangSheng Corporation Information

11.9.2 ChangSheng Overview

11.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 ChangSheng Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 ChangSheng Recent Developments

11.10 Convac

11.10.1 Convac Corporation Information

11.10.2 Convac Overview

11.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Convac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Convac Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Hepatitis A Vaccine Industry Chain Analysis

12.2 Hepatitis A Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Hepatitis A Vaccine Production Mode & Process

12.4 Hepatitis A Vaccine Sales and Marketing

12.4.1 Hepatitis A Vaccine Sales Channels

12.4.2 Hepatitis A Vaccine Distributors

12.5 Hepatitis A Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Hepatitis A Vaccine Industry Trends

13.2 Hepatitis A Vaccine Market Drivers

13.3 Hepatitis A Vaccine Market Challenges

13.4 Hepatitis A Vaccine Market Restraints

14 Key Findings in The Global Hepatitis A Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample